These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 19415900

  • 1. Small-molecule suppression of misfolding of mutated human carbonic anhydrase II linked to marble brain disease.
    Almstedt K, Rafstedt T, Supuran CT, Carlsson U, Hammarström P.
    Biochemistry; 2009 Jun 16; 48(23):5358-64. PubMed ID: 19415900
    [Abstract] [Full Text] [Related]

  • 2. Unfolding a folding disease: folding, misfolding and aggregation of the marble brain syndrome-associated mutant H107Y of human carbonic anhydrase II.
    Almstedt K, Lundqvist M, Carlsson J, Karlsson M, Persson B, Jonsson BH, Carlsson U, Hammarström P.
    J Mol Biol; 2004 Sep 10; 342(2):619-33. PubMed ID: 15327960
    [Abstract] [Full Text] [Related]

  • 3. Thermodynamic interrogation of a folding disease. Mutant mapping of position 107 in human carbonic anhydrase II linked to marble brain disease.
    Almstedt K, Mårtensson LG, Carlsson U, Hammarström P.
    Biochemistry; 2008 Feb 05; 47(5):1288-98. PubMed ID: 18189416
    [Abstract] [Full Text] [Related]

  • 4. Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes.
    Kasimoğullari R, Bülbül M, Günhan H, Güleryüz H.
    Bioorg Med Chem; 2009 May 01; 17(9):3295-301. PubMed ID: 19362844
    [Abstract] [Full Text] [Related]

  • 5. Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: Potential membrane-impermeable inhibitors of carbonic anhydrase.
    May JA, Namil A, Chen HH, Dantanarayana AP, Dupré B, Liao JC.
    Bioorg Med Chem; 2006 Mar 15; 14(6):2052-9. PubMed ID: 16297631
    [Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases.
    Nasr G, Petit E, Supuran CT, Winum JY, Barboiu M.
    Bioorg Med Chem Lett; 2009 Nov 01; 19(21):6014-7. PubMed ID: 19796939
    [Abstract] [Full Text] [Related]

  • 7. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices.
    Melagraki G, Afantitis A, Sarimveis H, Igglessi-Markopoulou O, Supuran CT.
    Bioorg Med Chem; 2006 Feb 15; 14(4):1108-14. PubMed ID: 16213737
    [Abstract] [Full Text] [Related]

  • 8. A new synthesis of difluoromethanesulfonamides--a novel pharmacophore for carbonic anhydrase inhibition.
    Boyle NA, Chegwidden WR, Blackburn GM.
    Org Biomol Chem; 2005 Jan 21; 3(2):222-4. PubMed ID: 15632962
    [Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT.
    Bioorg Med Chem; 2009 Jul 15; 17(14):4894-9. PubMed ID: 19539481
    [Abstract] [Full Text] [Related]

  • 10. Subtle differences in dissociation rates of interactions between destabilized human carbonic anhydrase II mutants and immobilized benzenesulfonamide inhibitors probed by a surface plasmon resonance biosensor.
    Svedhem S, Enander K, Karlsson M, Sjöbom H, Liedberg B, Löfås S, Mårtensson LG, Sjöstrand SE, Svensson S, Carlsson U, Lundström I.
    Anal Biochem; 2001 Sep 15; 296(2):188-96. PubMed ID: 11554714
    [Abstract] [Full Text] [Related]

  • 11. Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II.
    Banerjee AL, Swanson M, Roy BC, Jia X, Haldar MK, Mallik S, Srivastava DK.
    J Am Chem Soc; 2004 Sep 08; 126(35):10875-83. PubMed ID: 15339172
    [Abstract] [Full Text] [Related]

  • 12. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.
    Huang H, Pan X, Tan N, Zeng G, Ji C.
    Eur J Med Chem; 2007 Mar 08; 42(3):365-72. PubMed ID: 17118494
    [Abstract] [Full Text] [Related]

  • 13. Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors.
    Kockar F, Maresca A, Aydin M, Işik S, Turkoglu S, Sinan S, Arslan O, Güler OO, Turan Y, Supuran CT.
    Bioorg Med Chem; 2010 Aug 01; 18(15):5498-503. PubMed ID: 20624682
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols.
    Sentürk M, Gülçin I, Daştan A, Küfrevioğlu OI, Supuran CT.
    Bioorg Med Chem; 2009 Apr 15; 17(8):3207-11. PubMed ID: 19231207
    [Abstract] [Full Text] [Related]

  • 15. Reshaping the folding energy landscape of human carbonic anhydrase II by a single point genetic mutation Pro237His.
    Jiang Y, Su JT, Zhang J, Wei X, Yan YB, Zhou HM.
    Int J Biochem Cell Biol; 2008 Apr 15; 40(4):776-88. PubMed ID: 18060825
    [Abstract] [Full Text] [Related]

  • 16. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
    Smaine FZ, Pacchiano F, Rami M, Barragan-Montero V, Vullo D, Scozzafava A, Winum JY, Supuran CT.
    Bioorg Med Chem Lett; 2008 Dec 15; 18(24):6332-5. PubMed ID: 18990571
    [Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
    Wilkinson BL, Bornaghi LF, Houston TA, Innocenti A, Vullo D, Supuran CT, Poulsen SA.
    J Med Chem; 2007 Apr 05; 50(7):1651-7. PubMed ID: 17343373
    [Abstract] [Full Text] [Related]

  • 18. Reshaping the folding energy landscape by chloride salt: impact on molten-globule formation and aggregation behavior of carbonic anhydrase.
    Borén K, Grankvist H, Hammarström P, Carlsson U.
    FEBS Lett; 2004 May 21; 566(1-3):95-9. PubMed ID: 15147875
    [Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
    Winum JY, Thiry A, Cheikh KE, Dogné JM, Montero JL, Vullo D, Scozzafava A, Masereel B, Supuran CT.
    Bioorg Med Chem Lett; 2007 May 15; 17(10):2685-91. PubMed ID: 17376683
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
    Nishimori I, Minakuchi T, Onishi S, Vullo D, Cecchi A, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2007 Dec 01; 15(23):7229-36. PubMed ID: 17826101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.